Clinical Trial Update: Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer [Phase 2]

View source ↗

Summary

Phase II study of an adenovirus/PSA vaccine in men with hormone-refractory prostate cancer completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Adenovirus/PSA vaccine

Snippet

Sponsor: David M Lubaroff | Conditions: Hormone Refractory Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-04-28